Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Acorda plans to sell 3.38 million shares


Acorda Therapeutics Inc., a biotechnology company based in Hawthorne, announced today that it plans to sell 3.38 million shares of common stock in a public offering. Final terms of the offering will be disclosed in a future filing with the Securities and Exchange Commission, the company said. Acorda intends to use proceeds from the offering to complete a second Phase 3 trial of Fampridine-SR, a treatment for multiple sclerosis, and other business purposes. Banc of America Securities LLC and Deutsche Bank Securities are managing the offering, Acorda said.

This entry was posted on Monday, June 4th, 2007 at 4:24 pm by David Schepp. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Raising cash



Leave a Reply

About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.


Get blog updates via email:

About the Authors


Other recent entries


Recently Updated LoHud Blogs
Monthly Archives